Table 1.

Characteristics of NSV and ART-suppressed control participant cohorts

Characteristic		NSV (n = 8)	Control for HIV-1-specific CD8+ T cell (n = 7)	Control from ACTG (n = 11)
Sex, number (%)	Male	7 (88)	5 (71)	6 (42)
Age (years) (median [IQRa])		60 [55, 61]	62 [52, 68]	45 [40, 50]
Race/ethnicity (%)	African American	2 (25)	2 (29)	3 (27)
	Native American	1 (12)	0	0
	Caucasian	4 (50)	5 (71)	7 (63)
	Hispanic	1 (12)	0	1 (10)
Years on ART (median [IQR])		10 [7, 14]	12 [10, 13]	6 [5, 7]
Years with NSVb (median [IQR])		4 [3, 9]	NAd	NAd
Years with suppression (median [IQR])		2 [1, 7]	12 [10, 13]	6 [5, 7]
Viral load copies ml−1 (median [IQR])		143 [87, 536]	BLDe	BLDe
CD4 count cells µl−1 (median [IQR])		798 [581, 1,008]	793 [617, 949]	806 [713, 1,208]

^aIQR, interquartile range.

^bNSV, non-suppressible HIV-1 residual viremia.

^cVirologic suppression before the NSV.

^dNA, not applicable.

^eBLD, below level of detection (HIV-1 plasma viral below limit of detection).